Literature DB >> 7479545

The effect of pH and temperature on the self-association of recombinant human interleukin-2 as studied by equilibrium sedimentation.

S J Advant1, E H Braswell, C V Kumar, D S Kalonia.   

Abstract

The self-association of recombinant human interleukin-2 (rhIL-2) in solution was investigated as a function of pH and temperature using equilibrium sedimentation. Studies were performed at pH 3.6, 6.5 and 8.2, at 1 degree C and 20 degrees C. A model assuming an ideal single molecular species describes the data observed at pH 6.5 at both temperatures. At pH 8.2, the data from both temperatures can be better described by a weak monomer-dimer association equilibrium. The values of the association constants obtained indicate the presence of less than 10% dimer at a concentration of 1 mg/ml at both temperatures. At pH 3.6, aggregates with a Z average molecular weight of over 35 times that of monomeric rhIL-2 were formed. The smallest associating species present under these conditions corresponds to the monomer, which produces aggregates with a wide range of molecular weights. The monomer appears to be in equilibrium with the smallest aggregates, in that a model describing an indefinite association fits the data obtained at the highest centrifugal speed. No model was found to successfully describe the association of the monomer into the much larger aggregates observed at lower speeds. This may be the result of the lack of rapid thermodynamic reversibility of the larger aggregates. Temperature was found to have no significant effect on the largest aggregates that were formed at pH 3.6.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7479545     DOI: 10.1023/a:1016286920643

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

1.  The use of pH indicators to identify suitable environments for freezing samples in aqueous and mixed aqueous/nonaqueous solutions.

Authors:  J P Hill; P D Buckley
Journal:  Anal Biochem       Date:  1991-02-01       Impact factor: 3.365

2.  A sedimentation equilibrium study of the association of purine in aqueous solutions.

Authors:  K E Van Holde; G P Rossetti
Journal:  Biochemistry       Date:  1967-07       Impact factor: 3.162

Review 3.  Human recombinant interleukin-2 as an experimental therapeutic.

Authors:  J L Winkelhake; S S Gauny
Journal:  Pharmacol Rev       Date:  1990-03       Impact factor: 25.468

4.  Overview of the stability and handling of recombinant protein drugs.

Authors:  J Geigert
Journal:  J Parenter Sci Technol       Date:  1989 Sep-Oct

Review 5.  Stability of protein structure and hydrophobic interaction.

Authors:  P L Privalov; S J Gill
Journal:  Adv Protein Chem       Date:  1988

6.  Improved ultracentrifuge cells for high-speed sedimentation equilibrium studies with interference optics.

Authors:  A T Ansevin; D E Roark; D A Yphantis
Journal:  Anal Biochem       Date:  1970-03       Impact factor: 3.365

7.  Analysis of data from the analytical ultracentrifuge by nonlinear least-squares techniques.

Authors:  M L Johnson; J J Correia; D A Yphantis; H R Halvorson
Journal:  Biophys J       Date:  1981-12       Impact factor: 4.033

Review 8.  Interleukin-2: inception, impact, and implications.

Authors:  K A Smith
Journal:  Science       Date:  1988-05-27       Impact factor: 47.728

Review 9.  Comparative evaluation of multiple lymphoid and recombinant human interleukin-2 preparations.

Authors:  G B Thurman; A E Maluish; J L Rossio; E Schlick; K Onozaki; J E Talmadge; A D Procopio; J R Ortaldo; F W Ruscetti; H C Stevenson
Journal:  J Biol Response Mod       Date:  1986-02

10.  Interleukin-2 self-association.

Authors:  J D Fleischmann; D Wentworth; F Valencic; A L Imbembo; K A Koehler
Journal:  Biochem Biophys Res Commun       Date:  1988-04-29       Impact factor: 3.575

View more
  1 in total

1.  Binding of L-branched-chain amino acids causes a conformational change in BkdR.

Authors:  K T Madhusudhan; N Huang; E H Braswell; J R Sokatch
Journal:  J Bacteriol       Date:  1997-01       Impact factor: 3.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.